WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

2012 Global Lyme Disease Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country

Venture Planning Group (VPG), April 2012, Pages: 203

The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 203 pages and 11 tables

I. Introduction
II. Worldwide Market and Technology Overview
A. Background
-- Clinical Description
-- Clinical Case Definition
-- Laboratory Criteria for Diagnosis
-- Case Classification
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
-- Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
-- Immuno-PCR
-- QC-PCR
-- DAP-PCR
-- Ligase Chain Reaction
-- Branched DNA
-- Q-Beta Replicase
-- Nucleic-Acid Sequence-Based
-- Strand Displacement Activation
-- Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
-- Overview
-- ELISA
-- Dot Immunobinding Assays
-- Capillary Immunoassays
-- Particle-Membrane Capture Immunoassays
-- Enzyme Amplification
c. Fluorescent Immunoassays
-- Fluorescence Polarization
-- Time-Resolved Pulse Fluorescence
d. Luminescence
-- Chemiluminescence
-- Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
1--. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus

List of Tables

Major Companies Developing or Marketing Lyme Disease Tests
France
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Germany
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Italy
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Japan
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.K.
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Lyme Disease Testing Market Diagnostics Sales by Major Supplier

Customers who bought this item also bought